Willis Johnson & Associates, Inc. Bio Path Holdings Inc Transaction History

Willis Johnson & Associates, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 Apr 29, 2021	SELL	$3.63 - $11.77 $41,309 - $133,942	-11,380 Closed	0 $0
Q4 2020 Apr 13, 2021	BUY	$3.21 - $5.26 $36,529 - $59,858	11,380 New	11,380 $40,000

Ticker BPTH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,160,160
Market Cap $7.73M
Description
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the...

Get notified when there are updates to the investment portfolio of Willis Johnson & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Willis Johnson & Associates, Inc. with notifications on news.